ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TRI-LUMA
Pigmentation disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TRI-LUMA Rx

Generic Name and Formulations:
Hydroquinone 4%, fluocinolone acetonide 0.01%, tretinoin 0.05%; crm; contains sulfites, parabens.

Company:
Galderma Laboratories, Inc.

Therapeutic Use:

Indications for TRI-LUMA:

Short-term intermittent treatment of moderate to severe melasma of the face, with measures for sun avoidance including sunscreen use (SPF 30).

Adult:

Clean (use a mild, soap-free cleanser) and dry skin. Apply a thin film to affected area(s) and to ½ inch of surrounding normal skin once daily, at least 30 minutes before bedtime.

Children:

Not recommended.

Warnings/Precautions:

Do not occlude or use on eczema or sunburned skin. Avoid eyes, ears, mouth, angle of nose, mucous membranes, sun, UV light. Skin types V and VI (possible undesirable excessive bleaching). Discontinue if ochronosis, chemical irritation, hypersensitivity, or HPA axis suppression occurs. Increased irritation in extreme weather. Elderly. Pregnancy (Cat.C), nursing mothers: consider delaying use until after pregnancy/nursing.

Interactions:

Avoid photosensitizers, topical irritants, and drying agents.

Pharmacological Class:

Skin depigmenting agent + topical steroid + retinoid.

Adverse Reactions:

Local irritation (erythema, peeling, burning, dryness, pruritus), acne, paresthesia, telangiectasia, hyperesthesia, folliculitis, dermatitis, secondary infection, hypertrichosis, skin atrophy, striae, miliaria, HPA axis suppression.

How Supplied:

Crm—30g

Sign Up for Free e-newsletters